Operating CF
$1.85B
Capex
−$524.00M
Free Cash Flow
$1.33B
FCF Margin
+71.7%
Cash flow waterfall for Quest Diagnostics (DGX) — TTM through Q1 2026
Free cash flow: $1.33B
Cash flow breakdown for Quest Diagnostics (DGX) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $1.85B | $1.85B |
| Capital Expenditure | −$524.00M | $1.33B |
| Free Cash Flow | $1.33B | $1.33B |
| Acquisitions | −$139.00M | $1.19B |
| Other Investing | −$5.00M | $1.18B |
| Share Buybacks | −$450.00M | $732.00M |
| Dividends Paid | −$357.00M | $375.00M |
| Net Debt Change | −$218.00M | $157.00M |
| Other Financing & FX | $48.00M | $205.00M |
| Net Cash Increase | $205.00M | $205.00M |
- Operating Cash Flow$1.85B
- Capital Expenditure−$524.00M
- Free Cash Flow$1.33B
- Acquisitions−$139.00M
- Other Investing−$5.00M
- Share Buybacks−$450.00M
- Dividends Paid−$357.00M
- Net Debt Change−$218.00M
- Other Financing & FX$48.00M
- Net Cash Increase$205.00M
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
Quest Diagnostics (DGX) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement